Latest news
Loading news…
Xynomic Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Shanghai, China Founded 2016 11-50 employees For Profit
Xynomic Pharmaceuticals, Inc. is a clinical stage oncology-focused biopharmaceutical company.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
4
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- XYN
- Exchange
- NYSE - New York Stock Exchange
- IPO date
- May 15, 2019
- Delisted
- Jul 17, 2019
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
Company Info
- Founded
- 2016
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 7
- HQ
- Shanghai, China
- Region
- Asia-Pacific (APAC)
- Exit date
- May 15, 2019
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0.9
- Trend (90d)
- 1
4
professional contacts at Xynomic Pharmaceuticals
Contact execs at Xynomic Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Xynomic Pharmaceuticals
Loading news…
FAQs about Xynomic Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.